Pharmacy Insights With Faegre Drinker
Webinar
Overview
The pharmacy sector is on the front lines of the COVID-19 pandemic, the opioid epidemic and public health generally. Pharmacy Insights with Faegre Drinker offers conversations with pharmacy industry leaders who will share their experiences, spark discussions and — hopefully — inspire new collaborations.
Questions? Please contact Kelley Stephens or call +1 317 237 1161.
Webinars in This Series
Session One (Thursday, January 14, 2021) – The Latest in Pharmacy Practice, Policy and Regulation
In this first session, Catizone, Luce & Menighan (CLM) Pharmacy Advisors Founding Partner Dan Luce joined Faegre Drinker Partner Libby Baney to discuss significant changes in pharmacy practice and regulation, the current impact of these developments, and the pros and cons of allowing these adaptations to continue after the pandemic. Topics included both state authorizations and federal preemptions regarding interstate practice, and COVID-19 tests and vaccines.
Session Two (Tuesday, February 2, 2021) – Looking Ahead: Pharmacy Practice, Policy and Regulation
In this second session, NABP Solutions Executive Director Marty Allain joined Faegre Drinker Partner Libby Baney to discuss significant changes in pharmacy practice and regulation, the current impact of these developments, and the pros and cons of allowing these adaptations to continue after the pandemic. Speakers prognosticated on the future of pharmacy and patient care post-pandemic.
Session Three (Tuesday, March 2, 2021) – Navigating Managed Care
In this third session, former Executive Director of NABP and current Founding Partner of Catizone, Luce & Menighan Pharmacy Advisors Carmen Catizone joined Faegre Drinker Partner Jay Warmuth to discuss the impact of COVID-19, teleheatlh, and managed care on the practice of pharmacy, its continuing evolution and the role of state regulators.
Session 4 (Tuesday, May 4, 2021) – The Evolving Role of Pharmacists
In this fourth session, practicing pharmacists John Mennuti and Jake Crystal will join Faegre Drinker associate and co-leader of the Pharmacy & PBM Segment Jonathan Keller to discuss how COVID-19 has impacted the practice of pharmacy at their hospitals, the evolving role of pharmacists in health care and what actions can be taken to further advance the practice of pharmacy.
Session 5 (Tuesday, July 7, 2021) – New Drug Price Transparency Regulations and Tools: Consumer and Drug Pricing Implications
In this fifth session, Rx Savings Solutions (RxSS) founder and CEO Michael Rea will join Faegre Drinker principal Michael Adelberg to discuss new regulations requiring certain health plans to move toward drug price transparency and how this will impact consumers and industry. The speakers will elaborate on how RxSS, which serves nearly 8 million plan members with drug price transparency tools, can help plans comply with new regulations.
Session 6 (Monday, November 15, 2021) – Let’s Talk Telehealth and Online Pharmacy — Featuring hims & hers Chief Medical Officer Patrick Carroll
Increasingly, telehealth platforms are building, buying or contracting with third-party preferred pharmacies to offer patients a “one-stop-shop” health care experience. Participants will hear from Patrick Carroll, the chief medical officer for hims & hers, a company leading in this space, and Libby Baney, a Faegre Drinker partner in the government and regulatory affairs practice, to discuss business and consumer trends and legal developments relevant to both telehealth and pharmacy operations.
Session 7 (Tuesday, February 8, 2022) – USP Revisions: How Could You be Affected?
In September 2021, the United States Pharmacopeia (USP) issued a long-awaited Notice of Intent to Revise (NITR) for both USP Chapter <795> (nonsterile compounding) and USP Chapter <797> (sterile compounding). This NITR comes after the USP Appeals Panel granted appeals to USP’s prior revisions to Chapter <795> and USP Chapter <797> and ultimately remanded the chapters back to the Compounding Expert Committee for further stakeholder engagement. The proposed updates in the NITR will impact compounding practices around stability testing, beyond-use-dating and much more. Pharmacies and compounding facilities need to be prepared for the proposed revisions to USP Chapters <795> and <797>, as the new guidance may have a considerable impact on facility workflow and finances.
In this seventh session of Digital Health Insights, Amy Summers, PharmD, BCSCP, founder of Restore Health Consulting, joins Faegre Drinker Senior Associate Jonathan Keller to discuss the key changes proposed in the NITR to both USP Chapters <795> and <797> and present steps for assessing the potential impact on your compounding practice.
Continuing Education Credit
This program will be sent to the following state bars requesting approval: CA, CO, CT, DE, IA, IL, IN, MN, NJ, NY, PA, TX and VA.
All approvals are at the decision of the state bar based on content and deadlines.
No applications are currently pending.
The CLE provider for this event, CEU Institute (national CLE provider – www.ceuinstitute.net) will seek 1.5 hours General Law credit for this program.
Please check back closer to the event date for updated credit information.
Related Legal Services
Related Industries
Related Topics
Firm Speakers
